Method of Differentiating Mammalian Progenitor Cells into Insulin Producing Pancreatic Islet Cells
US 8,877,497 Grace period endedTerm ends Jun 16, 2031 · Low confidence
20-year base term ends May 21, 2029
Grace period ended Nov 4, 2026 · no payment on record as of the Nov 17, 2026 fee file · lapse expected
May 21, 2009
Jun 16, 2031
Nov 4, 2014
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 21, 2009, when this application, 12/470,247, was filed | May 21, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +756 days, USPTO patent term adjustment record | Jun 16, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | The grace period ended with no payment on record in the fee file | grace period ended Nov 4, 2026 | Low confidence |
| Computed term end | The steps above, in order | Jun 16, 2031 | Low confidence |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.